Protheragen-ING is a China-based comprehensive integrated service provider specializing in drug development and biotechnology solutions. The company offers both small molecule and large molecule (antibody, ADC, protein therapy) development and manufacturing services, with an extensive pipeline of available drug development projects spanning antibody therapies, oncolytic virotherapy, cell therapy (CAR-T), and small molecules. Protheragen is FDA-registered for API manufacture and operates project incubation and equity investment services for drug candidates.
integrated drug development services, antibody and ADC development, small molecule API synthesis, CAR-T cell therapy, drug project incubation and investment
2 sites worldwide
No reviews available yet.
No documents available.